Multivalent MVA-vectored vaccine elicits EBV neutralizing antibodies in rhesus macaques that reduce EBV infection in humanized mice
These results support the inclusion of multiple entry glycoproteins in EBV vaccine design and position our vaccine as a strong candidate for clinical translation.
Authors
- Gabriela M. Escalante (ORCID: https://orcid.org/0000-0003-3182-1947)
- Javier Gordon Ogembo (ORCID: https://orcid.org/0000-0001-6949-8693)
- Michael K. Axthelm (ORCID: https://orcid.org/0000-0002-1984-5906)
- Esther Rodríguez (ORCID: https://orcid.org/0000-0003-1837-1005)
- Mafalda A Farelo (ORCID: https://orcid.org/0000-0001-8590-0742)
- Ivana Gabriela Reidel (ORCID: https://orcid.org/0000-0001-8897-4421)
- Murali Muniraju (ORCID: https://orcid.org/0000-0003-4100-8781)
- Simeon Cua (ORCID: https://orcid.org/0000-0002-0608-0078)
- Lorraine Z. Mutsvunguma
- He Li (ORCID: https://orcid.org/0000-0001-7042-7251)
- Scott W. Wong (ORCID: https://orcid.org/0000-0001-6855-0808)
- Cloe Zimmerman
- Aparna Govindan
- Brenda A. Tello
Institutions
- Oregon National Primate Research Center (US)
- Oregon Health & Science University (US)
- City of Hope (US)
- Children's Cancer Therapy Development Institute (US)
- Beckman Research Institute
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-09-13
- DOI
- https://doi.org/10.3389/fimmu.2024.1445209
- Citations
- 6
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 2.32
Funders
- Oregon National Primate Research Center